Company Filing History:

11 out of 1,243

The Texas A&m University System

patents

2 out of 2

Amarillo Cell Culture Company, Incorporated

patents

1 out of 2,342

University of Illinois

patents

4. 1 out of 5

Amarillo Biosciences, Inc.

patents

5. 2 out of 832,812

Other

patents

Years Active: 1984-2017

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9642893 - Method for reducing injury and stabilizing muscle using orally administered interferon (2017-05-09),

2. 6656920 - Composition and method for promoting oral health (2003-12-02),

3. 6506377 - Interferon-alpha mediated upregulation of aquaporin expression (2003-01-14),

4. 6372218 - Interferon dosage form and method therefor (2002-04-16),

5. 5910304 - Low-dose oral administration of interferons (1999-06-08),

6. 5882640 - Treatment of hyperallergenic response with oral interferon (1999-03-16),

7. 5846526 - Treatment of autoimmune disorders with oral interferon (1998-12-08),

8. 5830456 - Treatment of viral disease with oral interferon-.alpha. (1998-11-03),

9. 5824300 - Treatment of neoplastic disease with oral interferon (1998-10-20),

10. 5817307 - Treatment of bacterial infection with oral interferon-.alpha. (1998-10-06),

11. 5215741 - Method for prevention of parasite infections (1993-06-01),

12. 5019382 - Treatment of immuno-resistant disease with low-dose interferon (1991-05-28),

13. 5017371 - Method for reducing side effects of cancer therapy (1991-05-21),

14. 4820515 - Method of using interferon in low dosage to regulate appetite and (1989-04-11),

15. 4820514 - Low dosage of interferon to enhance vaccine efficiency (1989-04-11),

Title: Joseph M Cummins: Innovator in Health and Wellness

Introduction

Joseph M Cummins is a notable inventor based in Amarillo, Texas, with a remarkable portfolio of 17 patents. His work primarily focuses on health and wellness, particularly in the areas of muscle injury treatment and oral health improvement.

Latest Patents

Among his latest patents is a method for reducing injury and stabilizing muscle using orally administered interferon. This patent outlines compositions and methods for treating or preventing muscle injury or diseases through the oral administration of low doses of type I and/or type III interferons. In one embodiment, a composition is administered that includes interferon-alpha and trehalose. Another significant patent is for a composition and method for promoting oral health. This invention relates to a method for increasing unstimulated whole saliva in a patient by orally administering an effective amount of a disaccharide, such as maltose or trehalose, in a dosage form like a lozenge. This method can also be combined with vitamin C or its derivatives to treat conditions such as Sjögren's syndrome and xerostomia.

Career Highlights

Joseph has had a distinguished career, contributing to significant advancements in health-related technologies. He has worked with reputable organizations, including the Texas A&M University System and Amarillo Cell Culture Company, Incorporated. His innovative approaches have garnered attention in the scientific community.

Collaborations

Throughout his career, Joseph has collaborated with notable individuals such as Philip C Fox and Martin Joseph Cummins. These collaborations have further enriched his research and development efforts.

Conclusion

Joseph M Cummins stands out as a dedicated inventor whose contributions to health and wellness continue to make a significant impact. His innovative patents reflect his commitment to improving the quality of life through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com